# NSN 6505-01-200-2474: Naproxen Tablets

NSN 6505-01-200-2474 (also written 6505012002474; NIIN 01-200-2474) is a naproxen tablets in Federal Supply Class 6505, Drugs and Biologicals. 2 manufacturer part numbers from 2 suppliers are on record. It was last purchased in Oct 2026.

## Identification

- NSN: 6505-01-200-2474 (6505012002474)
- NIIN: 01-200-2474 (012002474)
- Item name: NAPROXEN TABLETS
- Federal Supply Class: [FSC 6505 Drugs and Biologicals](https://nsnexplorer.com/fsc/6505/)
- Federal Supply Group: [FSG 65](https://nsnexplorer.com/group/65/)
- Acquisition method suffix code: AMSC 0 (observed 2026-10-10)
- Acquisition method code: 0

## Characteristics

| Code | Requirement | Reply |
| --- | --- | --- |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS NAPROXEN ACTIVE INGREDIENT 500.000 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | TABLETS 100.000 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | NAPROXEN TABLETS USP 500 MG 100S |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |

## Part numbers

| Part number | CAGE | Supplier | Source |
| --- | --- | --- | --- |
| NDC53746-0190-01 | 557X3 | AMNEAL PHARMACEUTICALS OF NEW YORK, LLC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC76282-0342-01 | 6GFC4 | EXELAN PHARMACEUTICALS INC DIV EXELAN PHARMACEUTICALS | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |

## Contract awards

Newest first.

| Date | Award | Description | Recipient | Amount |
| --- | --- | --- | --- | --- |
| 2026-10-07 | [SPE2DX25D9822/SPE2D227F0006](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012002474) | NAPROXEN TABLETS | DMS PHARMACEUTICAL GROUP INC | $3.69 |
| 2026-09-28 | [SPE2DX25D9900/SPE2DP26F023K](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012002474) | NAPROXEN TABLETS | DMS PHARMACEUTICAL GROUP INC | $14.67 |
| 2026-09-25 | [SPE2DX25D9900/SPE2DP26F018R](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012002474) | NAPROXEN TABLETS | DMS PHARMACEUTICAL GROUP INC | $24.45 |
| 2026-09-22 | [SPE2DX25D9900/SPE2DP26F004R](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012002474) | NAPROXEN TABLETS | DMS PHARMACEUTICAL GROUP INC | $48.90 |

## Sources

- DLA DIBBS RFQs for this NSN: https://www.dibbs.bsm.dla.mil/RFQ/RFQNsn.aspx?value=6505012002474&category=nsn
- DLA DIBBS awards for this NSN: https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012002474
- AMSC record: https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/
- USAspending contract actions (each award above links to its record)
- All data is public U.S. government data; every row above links to its source record where one exists.

Canonical page: https://nsnexplorer.com/nsn/6505-01-200-2474/
JSON: https://nsnexplorer.com/api/nsn/6505-01-200-2474.json